New Parkinson's Drug Candidate Cuts Side Effects in Study

Scientists at UC San Diego have developed a drug that could help millions of Parkinson's patients get better relief from their symptoms without the involuntary movements that plague current treatments.

The compound, called SB-0110, showed promising results in animal studies by boosting the benefits of the standard medication while reducing its worst side effects.